Testbiotech comment on EFSA’s assessment of genetically engineered maize MON88017 for renewal authorisation under Regulation (EC) No 1829/2003 (application EFSA-GMO-RX-014) from Bayer/Monsanto (April 2020)

The EFSA GMO panel assessed genetically engineered maize MON88017 for renewal of authorisation. This maize produces
• Cry3Bb1 protein against the larvae of Coleoptera (beetles) that feed below the ground;
• CP4 EPSPS protein for tolerance to glyphosate-containing herbicides.

Implementing Regulation 503/2013 was applied in the EFSA risk assessment.